We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.6B
AUM Growth
+$2.03B
Cap. Flow
+$1.28B
Cap. Flow %
5.2%
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 33.15%
2 Consumer Discretionary 10.25%
3 Communication Services 8.94%
4 Healthcare 6.61%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CART icon
1201
Maplebear
CART
$11.4B
$73.2K ﹤0.01%
1,734
-133
-7% -$5.76K
BURL icon
1202
Burlington
BURL
$22.4B
$72.9K ﹤0.01%
256
-2
-0.8% -$540
IDYA icon
1203
IDEAYA Biosciences
IDYA
$3.55B
$72.5K ﹤0.01%
2,880
-176
-6% -$4.98K
UE icon
1204
Urban Edge Properties
UE
$2.76B
$72.4K ﹤0.01%
3,386
-1,226
-27% -$27.3K
CIB icon
1205
Grupo Cibest SA
CIB
$22.9B
$71.7K ﹤0.01%
2,246
+657
+41% +$21.2K
FCPT icon
1206
Four Corners Property Trust
FCPT
$2.76B
$71K ﹤0.01%
2,586
-984
-28% -$28.1K
AKR icon
1207
Acadia Realty Trust
AKR
$2.86B
$70.5K ﹤0.01%
2,939
-1,066
-27% -$26.1K
TARS icon
1208
Tarsus Pharmaceuticals
TARS
$3.01B
$70.1K ﹤0.01%
1,274
-102
-7% -$4.63K
WCC
1209
WESCO International
WCC
$17.7B
$68.9K ﹤0.01%
386
-509
-57% -$96.2K
LGND icon
1210
Ligand Pharmaceuticals
LGND
$5.74B
$68.8K ﹤0.01%
630
-31
-5% -$3.5K
APGE icon
1211
Apogee Therapeutics
APGE
$10.2B
$68.7K ﹤0.01%
1,500
-128
-8% -$6.53K
SUPN icon
1212
Supernus Pharmaceuticals
SUPN
$2.74B
$68.4K ﹤0.01%
1,840
-153
-8% -$5.39K
SNX icon
1213
TD Synnex
SNX
$20.6B
$68.4K ﹤0.01%
578
-831
-59% -$99.5K
CGON icon
1214
CG Oncology
CGON
$6.69B
$67.7K ﹤0.01%
+2,254
New +$77.1K
AZPN
1215
DELISTED
Aspen Technology Inc
AZPN
$67.5K ﹤0.01%
270
+151
+127% +$36.8K
LXP icon
1216
LXP Industrial Trust
LXP
$3.58B
$67.5K ﹤0.01%
1,643
-642
-28% -$29.7K
GERN icon
1217
Geron
GERN
$994M
$67.5K ﹤0.01%
20,144
-1,658
-8% -$6.62K
RPM icon
1218
RPM International
RPM
$14.5B
$67K ﹤0.01%
544
-995
-65% -$131K
SMG icon
1219
ScottsMiracle-Gro
SMG
$3.58B
$66.8K ﹤0.01%
1,012
-500
-33% -$39.5K
MIRM icon
1220
Mirum Pharmaceuticals
MIRM
$6.03B
$66.5K ﹤0.01%
1,600
-125
-7% -$5.21K
CNM icon
1221
Core & Main
CNM
$8.64B
$66.3K ﹤0.01%
1,300
-723
-36% -$34.1K
PVH icon
1222
PVH
PVH
$3.77B
$65.9K ﹤0.01%
613
-53
-8% -$5.43K
AKRO
1223
DELISTED
Akero Therapeutics
AKRO
$65.7K ﹤0.01%
2,326
-185
-7% -$5.6K
WVE icon
1224
Wave Life Sciences
WVE
$1.04B
$65.6K ﹤0.01%
5,082
+570
+13% +$7.61K
UFOX
1225
Defiance Space and Connective Tech ETF
UFOX
$925M
$65.1K ﹤0.01%
1,355

Similar funds

Mirae Asset Global Investments's Q4 2024 Portfolio in Review

As of Q4 2024, Mirae Asset Global Investments held 1,702 positions worth $24.6B, up 9% from $22.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mirae Asset Global Investments deployed $1.28B of net new capital in Q4 2024, opening 151 new positions and adding to 731 existing holdings. Its largest new stake was Strategy Inc: 36,162 shares worth $11.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $81.5M trimmed.

  • Mirae Asset Global Investments's largest Q4 2024 buy was Strategy Inc: 36,162 shares worth $11.8M.
  • Mirae Asset Global Investments added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $167M increase.
  • Mirae Asset Global Investments's biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $81.5M.
  • Mirae Asset Global Investments fully exited VanEck Pharmaceutical ETF in Q4 2024, selling an estimated $23.6M.
  • Mirae Asset Global Investments's ten largest holdings make up 38% of its $24.6B portfolio in Q4 2024.
  • Mirae Asset Global Investments opened 151 new positions and closed 110 in Q4 2024.
  • Mirae Asset Global Investments's portfolio value rose 9% quarter-over-quarter to $24.6B.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.